Re: prednisone side effects

February 19, 2009

That is definitely the prednisone. I have gotten pretty good at

bringing blood when I bite my tongue to keep from yelling at the kids,

but my poor husband....... Sometimes I can't seem to control it. The

worst part is I recognize when I am being irrational, but if I try to

tamp it down it just makes it worse. So I have found the best thing

to do is just excuse myself from the room and go scream into my

pillow. I just bought a $4 punching bag from the Dollar Store. I set

it up in the corner so it doesn't go all the way to the floor when I

hit it. I ended up laughing last night after watching it bounce

around a bit. As far as memory, mine is called an organizer. If it

is not written down in my organizer it is not going to get done. I

also walk around the house with a pencil and little notebook in my

pocket. Make myself little notes about anything I want to remember.

It takes some effort to get into the habit of doing these things, but

once you get used to it it's easy to keep up with.

Madeline

> >

> > >

> > > Hi every one.. How are you?? Good?!!!

> > >

> > > I am feeling much better!! Thank God for that!. I am breathing a

> > little

> > > bit more and I only use the nebulizer 2 or 3 times a day... Instead

> > of 6.. I

> > > am so so happy!!.

> > >

> > > I am reducing my prednisone dosis as the doctor told me. After 5

> > days

> > > with 40mg in the morning and 20 at night, today is my 3rd day with

> > just 40

> > > in the morning. Last night I had a strange amm crisis?. It was 1:30

> > am or so

> > > (you know I can't sleep at night because of the Prednisone plus I

> > can't take

> > > pills to sleep); and I start to feel panic, out of nothing! I don't

> > know..

> > > instantly, I was even shaking full of fear of " unknown causes " .. is

> > that due

> > > to the prednisone?. The Good thing is that that didnt end up in an

> > asthma

> > > attack, but to be honest (I am full of shame to admit it), I was

even

> > > feeling " scared " to sleep!, just like I was going to die

sleeeping or

> > > something like that.. never had this issues before.. should I told

> > my doctor

> > > about this?. Is also normal to have like a burry vision when

your taking

> > > prednisone? will that be gone once I stop using it?.

> > >

> > > Today my boss called me to see if I was feeling better so I

> > could go to

> > > work. It's very cold and when I picked up the phone, I was using the

> > > nebulizer so, she told me to take this day also... Thank God!

because it

> > > just started to rain a few minutes after the call. To be honest,

> > lol, I'm

> > > kind of scare to be outside the house.. I'm so scarry, I hate it!!,

> > but I am

> > > . Oh well.

> > >

> > > Well, I hope you all have a wonderful St. Valentines day, and i hope

> > you are

> > > enjoying your long weeekend..

> > >

> > > Hugs!!

> > >

> >

>

February 23, 2009

Jan

I have to say that I am envious of your menstral problems. I have the exact opposite problem in that I NEVER stop. For about 3 and a half years now it has been constant. And not just spotting but full on bleeding. TMI I know but a huge pain and probably prednisone related somehow.

I have a SEVERE potassium deficiency but they don't think mine is solely pred related. It is too significant and hit too fast. I am on 140 mEq IV a day plus 240mEq oral. And I still test in the low 2s frequently.

Subject: Re: Re: prednisone side effectsTo: asthma Date: Sunday, February 22, 2009, 8:24 PM

-- no menstruation and such --

Do you have problems with your potassium? I have -- from the Pred and asthma medications. They deplete my potassium. I am always low on it so I take supplements (doctor-prescribed too because the dose is outside of the normal non-prescription stuff) and sometimes have to be in the hospital for IV potassium. I have heart issues and the low potassium messes up my heart even more so I can't just ignore it.

Recent Activity

8

New MembersVisit Your Group

Give Back

Yahoo! for Good

Get inspired

by a good cause.

Y! Toolbar

Get it Free!

easy 1-click access

to your groups.

Yahoo! Groups

Start a group

in 3 easy steps.

Connect with others.

..

February 23, 2009

Have they considered a hysterectomy on you?

Terry I know God will not give me anything I can't handle. I just wish that He didn't trust me so much. ~Mother Teddy Bear's Early Learning ProgramEstablished August of 1992

From: asthma [mailto:asthma ] On Behalf Of Sent: Monday, February 23, 2009 10:27 AMTo: asthma Subject: Re: Re: prednisone side effects

Jan

I have to say that I am envious of your menstral problems. I have the exact opposite problem in that I NEVER stop. For about 3 and a half years now it has been constant. And not just spotting but full on bleeding. TMI I know but a huge pain and probably prednisone related somehow.

I have a SEVERE potassium deficiency but they don't think mine is solely pred related. It is too significant and hit too fast. I am on 140 mEq IV a day plus 240mEq oral. And I still test in the low 2s frequently.

From: iamatoughcookie <iamatoughcookiegmail>Subject: Re: Re: prednisone side effectsTo: asthma Date: Sunday, February 22, 2009, 8:24 PM

-- no menstruation and such --

Do you have problems with your potassium? I have -- from the Pred and asthma medications. They deplete my potassium. I am always low on it so I take supplements (doctor-prescribed too because the dose is outside of the normal non-prescription stuff) and sometimes have to be in the hospital for IV potassium. I have heart issues and the low potassium messes up my heart even more so I can't just ignore it.

Recent Activity

8

New MembersVisit Your Group

Give Back

Yahoo! for Good

Get inspired

by a good cause.

Y! Toolbar

Get it Free!

easy 1-click access

to your groups.

Yahoo! Groups

Start a group

in 3 easy steps.

Connect with others. .

February 24, 2009

Thanks Jan. The only thing that is going to help is to get off the

prednisone, or at least reduce the levels quite a bit. I have just

started Imuran and have to build it up for 6 weeks before we try to

start a step down again. So, take supplements, weekly bloodwork to

check all of my immunity factors, vitamin/mineral levels, and kidney

function. Monthly testing on the hormone and thyroid levels. The

list never ends. Yes, I am with you on the walking pharmacy. I think

I keep the drugstore in business singlehandedly. LOL!

Madeline

> > > > > > >

> > > > > > > Please pay attention to the sentance with the bold word

WITHOUT

> > > > in it.

> > > > > > >

> > > > > > > An FDA advisory panel recently voted to ban use of Serevent

> > > > (salmeterol)

> > > > > > > and Foradil (formoterol) for treatment of asthma in

children and

> > > > adults.

> > > > > > >

> > > > > > > Some data suggest that use of long-acting Î²-agonists

(LABAs)

> > > > without

> > > > > > > an inhaled corticosteroid (ICS) increases the risk for

> > severe asthma

> > > > > > > exacerbations and could be associated with death in

children and

> > > > adults.

> > > > > > > Based on a comprehensive review and meta-analysis of data

> > from 110

> > > > > > > trials involving 60,954 subjects, an FDA advisory panel

recently

> > > > voted

> > > > > > > to ban use of two LABAs - Serevent (salmeterol) and Foradil

> > > > (formoterol)

> > > > > > > - for treatment of asthma in children and adults. The

advisory

> > > > panel did

> > > > > > > not ban the two LABA-ICS combination drugs, Advair

> > (salmeterol and

> > > > > > > fluticasone) and Symbicort (formoterol and budesonide).

> > > > Symbicort is not

> > > > > > > approved for use in children.

> > > > > > >

> > > > > > > Overall comparison between LABA and non-LABA treatments

> > > > (including ICS

> > > > > > > alone, short-acting Î²-agonists, and placebo) showed that

> > LABAs were

> > > > > > > associated with significantly increased risk for

asthma-related

> > > > events.

> > > > > > > The overall risk-difference estimate for the composite

endpoint

> > > > > > > (asthma-related deaths, intubation, and hospitalization) of

> > the LABA

> > > > > > > rate minus the non-LABA rate was significant (2.80 per 1000

> > > > subjects).

> > > > > > > All 20 asthma-related deaths were in Serevent recipients; 16

> > > > occurred in

> > > > > > > LABA recipients and 4 in non-LABA recipients. In subgroup

> > > > analysis, risk

> > > > > > > was increased with three of the four drugs (Foradil,

> > Serevent, and

> > > > > > > Symbicort). The highest risk-difference estimates for the

> > composite

> > > > > > > endpoint were in children aged 4-11 years (14.8 per 1000

> > > > subjects) among

> > > > > > > age groups and in blacks (8.1 per 1000 subjects) among race

> > > > subgroups.

> > > > > > >

> > > > > > > Comment: Overall, Advair is clearly the most popular of

the four

> > > > drugs,

> > > > > > > with annual worldwide sales of US$5.7 billion (compared with

> > > > US$209-$538

> > > > > > > million for the other 3 drugs). In children and adolescents,

> > use of

> > > > > > > Advair is common, and use of the other three drugs is

> > limited. For

> > > > > > > children whose asthma symptoms are not controlled with

> > low-dose ICS,

> > > > > > > questions remain about whether increasing the ICS dose

is better

> > > > than

> > > > > > > adding other drugs. Current National Heart, Lung and Blood

> > Institute

> > > > > > > stepwise recommendations for management of asthma

> > > > > > >

> > > >

<http://imageb.epocrates.com/mailbot/links?EdID=39985581 & LinkID=35731>

> > > > > > > are as follows:

> > > > > > >

> > > > > > > Children aged <5 years:

> > > > > > > -Step 3 care: medium-dose ICS

> > > > > > > -Step 4 care: medium-dose ICS plus either LABA or

montelukast

> > > > > > >

> > > > > > > Children aged 5-11 years:

> > > > > > > -Step 3 care: either low-dose ICS plus LABA, a leukotriene

> > > > inhibitor, or

> > > > > > > theophylline; or medium-dose ICS

> > > > > > > -Step 4 care: medium-dose ICS plus LABA

> > > > > > >

> > > > > > > - Bauchner, MD

> > > > > > >

> > > >

<http://imageb.epocrates.com/mailbot/links?EdID=39985581 & LinkID=35733>

> > > > > > >

> > > > > > > Published in Journal Watch Pediatrics and Adolescent

Medicine

> > > > December

> > > > > > > 24, 2008

> > > > > > >

> > > > > >

> > > > >

> > > >

> > >

> >

>

February 24, 2009

Hi Madeline,That's right, I remember, you were starting Imuran yesterday, the other day, today (okay, I don't really know -- depends on where you are). What dose are you on? And what is the dose you are supposed to build up to?

I can't remember if you mentioned (sorry, pred head), but what dose of pred are you on right now? I am still on 1500-2000mg/day IV (depending on symptoms), but hoping to switch to 120-150mg/day oral soon. I am with you in wanting to get off the pred or at least reduce the levels.

To add to the countless medications, don't you get tired of going to the hospital/laboratory for the tests? When I am not in the hospital (admitted), I go 2-3 times per week for tests alone. I just want to take a break, you know.

We indeed keep the drugstores in business. I am VIP in mine already. Hahahaha!Jan

Thanks Jan. The only thing that is going to help is to get off the

prednisone, or at least reduce the levels quite a bit. I have just

started Imuran and have to build it up for 6 weeks before we try to

start a step down again. So, take supplements, weekly bloodwork to

check all of my immunity factors, vitamin/mineral levels, and kidney

function. Monthly testing on the hormone and thyroid levels. The

list never ends. Yes, I am with you on the walking pharmacy. I think

I keep the drugstore in business singlehandedly. LOL!

Madeline

> > > > > > >

> > > > > > > Please pay attention to the sentance with the bold word

WITHOUT

> > > > in it.

> > > > > > >

> > > > > > > An FDA advisory panel recently voted to ban use of Serevent

> > > > (salmeterol)

> > > > > > > and Foradil (formoterol) for treatment of asthma in

children and

> > > > adults.

> > > > > > >

> > > > > > > Some data suggest that use of long-acting Î²-agonists

(LABAs)

> > > > without

> > > > > > > an inhaled corticosteroid (ICS) increases the risk for

> > severe asthma

> > > > > > > exacerbations and could be associated with death in

children and

> > > > adults.

> > > > > > > Based on a comprehensive review and meta-analysis of data

> > from 110

> > > > > > > trials involving 60,954 subjects, an FDA advisory panel

recently

> > > > voted

> > > > > > > to ban use of two LABAs - Serevent (salmeterol) and Foradil

> > > > (formoterol)

> > > > > > > - for treatment of asthma in children and adults. The

advisory

> > > > panel did

> > > > > > > not ban the two LABA-ICS combination drugs, Advair

> > (salmeterol and

> > > > > > > fluticasone) and Symbicort (formoterol and budesonide).

> > > > Symbicort is not

> > > > > > > approved for use in children.

> > > > > > >

> > > > > > > Overall comparison between LABA and non-LABA treatments

> > > > (including ICS

> > > > > > > alone, short-acting Î²-agonists, and placebo) showed that

> > LABAs were

> > > > > > > associated with significantly increased risk for

asthma-related

> > > > events.

> > > > > > > The overall risk-difference estimate for the composite

endpoint

> > > > > > > (asthma-related deaths, intubation, and hospitalization) of

> > the LABA

> > > > > > > rate minus the non-LABA rate was significant (2.80 per 1000

> > > > subjects).

> > > > > > > All 20 asthma-related deaths were in Serevent recipients; 16

> > > > occurred in

> > > > > > > LABA recipients and 4 in non-LABA recipients. In subgroup

> > > > analysis, risk

> > > > > > > was increased with three of the four drugs (Foradil,

> > Serevent, and

> > > > > > > Symbicort). The highest risk-difference estimates for the

> > composite

> > > > > > > endpoint were in children aged 4-11 years (14.8 per 1000

> > > > subjects) among

> > > > > > > age groups and in blacks (8.1 per 1000 subjects) among race

> > > > subgroups.

> > > > > > >

> > > > > > > Comment: Overall, Advair is clearly the most popular of

the four

> > > > drugs,

> > > > > > > with annual worldwide sales of US$5.7 billion (compared with

> > > > US$209-$538

> > > > > > > million for the other 3 drugs). In children and adolescents,

> > use of

> > > > > > > Advair is common, and use of the other three drugs is

> > limited. For

> > > > > > > children whose asthma symptoms are not controlled with

> > low-dose ICS,

> > > > > > > questions remain about whether increasing the ICS dose

is better

> > > > than

> > > > > > > adding other drugs. Current National Heart, Lung and Blood

> > Institute

> > > > > > > stepwise recommendations for management of asthma

> > > > > > >

> > > >

<http://imageb.epocrates.com/mailbot/links?EdID=39985581 & LinkID=35731>

> > > > > > > are as follows:

> > > > > > >

> > > > > > > Children aged <5 years:

> > > > > > > -Step 3 care: medium-dose ICS

> > > > > > > -Step 4 care: medium-dose ICS plus either LABA or

montelukast

> > > > > > >

> > > > > > > Children aged 5-11 years:

> > > > > > > -Step 3 care: either low-dose ICS plus LABA, a leukotriene

> > > > inhibitor, or

> > > > > > > theophylline; or medium-dose ICS

> > > > > > > -Step 4 care: medium-dose ICS plus LABA

> > > > > > >

> > > > > > > - Bauchner, MD

> > > > > > >

> > > >

<http://imageb.epocrates.com/mailbot/links?EdID=39985581 & LinkID=35733>

> > > > > > >

> > > > > > > Published in Journal Watch Pediatrics and Adolescent

Medicine

> > > > December

> > > > > > > 24, 2008

> > > > > > >

> > > > > >

> > > > >

> > > >

> > >

> >

>

February 24, 2009

Comparative to you my prednisone level is just a drop in the bucket.

55mg/day, but I have been at this level or higher for close to a year.

The real issues didn't start until about the end of July. Imuran -

started it yesterday - 50mg/day for two weeks, then 100mg/day for 2

weeks, then 150mg/day. I just did another post on it.

Madeline

> > > > > > > > >

> > > > > > > > > Please pay attention to the sentance with the bold word

> > WITHOUT

> > > > > > in it.

> > > > > > > > >

> > > > > > > > > An FDA advisory panel recently voted to ban use of

Serevent

> > > > > > (salmeterol)

> > > > > > > > > and Foradil (formoterol) for treatment of asthma in

> > children and

> > > > > > adults.

> > > > > > > > >

> > > > > > > > > Some data suggest that use of long-acting Î²-agonists

> > (LABAs)

> > > > > > without

> > > > > > > > > an inhaled corticosteroid (ICS) increases the risk for

> > > > severe asthma

> > > > > > > > > exacerbations and could be associated with death in

> > children and

> > > > > > adults.

> > > > > > > > > Based on a comprehensive review and meta-analysis of

data

> > > > from 110

> > > > > > > > > trials involving 60,954 subjects, an FDA advisory panel

> > recently

> > > > > > voted

> > > > > > > > > to ban use of two LABAs - Serevent (salmeterol) and

Foradil

> > > > > > (formoterol)

> > > > > > > > > - for treatment of asthma in children and adults. The

> > advisory

> > > > > > panel did

> > > > > > > > > not ban the two LABA-ICS combination drugs, Advair

> > > > (salmeterol and

> > > > > > > > > fluticasone) and Symbicort (formoterol and budesonide).

> > > > > > Symbicort is not

> > > > > > > > > approved for use in children.

> > > > > > > > >

> > > > > > > > > Overall comparison between LABA and non-LABA treatments

> > > > > > (including ICS

> > > > > > > > > alone, short-acting Î²-agonists, and placebo) showed

that

> > > > LABAs were

> > > > > > > > > associated with significantly increased risk for

> > asthma-related

> > > > > > events.

> > > > > > > > > The overall risk-difference estimate for the composite

> > endpoint

> > > > > > > > > (asthma-related deaths, intubation, and

hospitalization) of

> > > > the LABA

> > > > > > > > > rate minus the non-LABA rate was significant (2.80

per 1000

> > > > > > subjects).

> > > > > > > > > All 20 asthma-related deaths were in Serevent

recipients; 16

> > > > > > occurred in

> > > > > > > > > LABA recipients and 4 in non-LABA recipients. In

subgroup

> > > > > > analysis, risk

> > > > > > > > > was increased with three of the four drugs (Foradil,

> > > > Serevent, and

> > > > > > > > > Symbicort). The highest risk-difference estimates

for the

> > > > composite

> > > > > > > > > endpoint were in children aged 4-11 years (14.8 per 1000

> > > > > > subjects) among

> > > > > > > > > age groups and in blacks (8.1 per 1000 subjects)

among race

> > > > > > subgroups.

> > > > > > > > >

> > > > > > > > > Comment: Overall, Advair is clearly the most popular of

> > the four

> > > > > > drugs,

> > > > > > > > > with annual worldwide sales of US$5.7 billion

(compared with

> > > > > > US$209-$538

> > > > > > > > > million for the other 3 drugs). In children and

adolescents,

> > > > use of

> > > > > > > > > Advair is common, and use of the other three drugs is

> > > > limited. For

> > > > > > > > > children whose asthma symptoms are not controlled with

> > > > low-dose ICS,

> > > > > > > > > questions remain about whether increasing the ICS dose

> > is better

> > > > > > than

> > > > > > > > > adding other drugs. Current National Heart, Lung and

Blood

> > > > Institute

> > > > > > > > > stepwise recommendations for management of asthma

> > > > > > > > >

> > > > > >

> > <http://imageb.epocrates.com/mailbot/links?EdID=39985581 & LinkID=35731>

> > > > > > > > > are as follows:

> > > > > > > > >

> > > > > > > > > Children aged <5 years:

> > > > > > > > > -Step 3 care: medium-dose ICS

> > > > > > > > > -Step 4 care: medium-dose ICS plus either LABA or

> > montelukast

> > > > > > > > >

> > > > > > > > > Children aged 5-11 years:

> > > > > > > > > -Step 3 care: either low-dose ICS plus LABA, a

leukotriene

> > > > > > inhibitor, or

> > > > > > > > > theophylline; or medium-dose ICS

> > > > > > > > > -Step 4 care: medium-dose ICS plus LABA

> > > > > > > > >

> > > > > > > > > - Bauchner, MD

> > > > > > > > >

> > > > > >

> > <http://imageb.epocrates.com/mailbot/links?EdID=39985581 & LinkID=35733>

> > > > > > > > >

> > > > > > > > > Published in Journal Watch Pediatrics and Adolescent

> > Medicine

> > > > > > December

> > > > > > > > > 24, 2008

> > > > > > > > >

> > > > > > > >

> > > > > > >

> > > > > >

> > > > >

> > > >

> > >

> >

>

February 24, 2009

I think 55mg/day is still generally considered high dose. How I wish we really could go down on the prednisone -- without making our illnesses worse. My prednisone higher than yours, most likely because I have several other autoimmune/inflammatory issues other than asthma. Still, that doesn't really make a huge difference, does it? We still get the fun of the side effects and all at high doses be it 55 or 150 -- sometimes people get the side effects even at lower doses. It really varies from person to person and the diseases being treated.

I will try to find your other post about Imuran. As far as I can remember, I started Imuran at 100mg/day and worked up to 250mg/day. Jan

Comparative to you my prednisone level is just a drop in the bucket.

55mg/day, but I have been at this level or higher for close to a year.

The real issues didn't start until about the end of July. Imuran -

started it yesterday - 50mg/day for two weeks, then 100mg/day for 2

weeks, then 150mg/day. I just did another post on it.

Madeline

> > > > > > > > >

> > > > > > > > > Please pay attention to the sentance with the bold word

> > WITHOUT

> > > > > > in it.

> > > > > > > > >

> > > > > > > > > An FDA advisory panel recently voted to ban use of

Serevent

> > > > > > (salmeterol)

> > > > > > > > > and Foradil (formoterol) for treatment of asthma in

> > children and

> > > > > > adults.

> > > > > > > > >

> > > > > > > > > Some data suggest that use of long-acting Î²-agonists

> > (LABAs)

> > > > > > without

> > > > > > > > > an inhaled corticosteroid (ICS) increases the risk for

> > > > severe asthma

> > > > > > > > > exacerbations and could be associated with death in

> > children and

> > > > > > adults.

> > > > > > > > > Based on a comprehensive review and meta-analysis of

data

> > > > from 110

> > > > > > > > > trials involving 60,954 subjects, an FDA advisory panel

> > recently

> > > > > > voted

> > > > > > > > > to ban use of two LABAs - Serevent (salmeterol) and

Foradil

> > > > > > (formoterol)

> > > > > > > > > - for treatment of asthma in children and adults. The

> > advisory

> > > > > > panel did

> > > > > > > > > not ban the two LABA-ICS combination drugs, Advair

> > > > (salmeterol and

> > > > > > > > > fluticasone) and Symbicort (formoterol and budesonide).

> > > > > > Symbicort is not

> > > > > > > > > approved for use in children.

> > > > > > > > >

> > > > > > > > > Overall comparison between LABA and non-LABA treatments

> > > > > > (including ICS

> > > > > > > > > alone, short-acting Î²-agonists, and placebo) showed

that

> > > > LABAs were

> > > > > > > > > associated with significantly increased risk for

> > asthma-related

> > > > > > events.

> > > > > > > > > The overall risk-difference estimate for the composite

> > endpoint

> > > > > > > > > (asthma-related deaths, intubation, and

hospitalization) of

> > > > the LABA

> > > > > > > > > rate minus the non-LABA rate was significant (2.80

per 1000

> > > > > > subjects).

> > > > > > > > > All 20 asthma-related deaths were in Serevent

recipients; 16

> > > > > > occurred in

> > > > > > > > > LABA recipients and 4 in non-LABA recipients. In

subgroup

> > > > > > analysis, risk

> > > > > > > > > was increased with three of the four drugs (Foradil,

> > > > Serevent, and

> > > > > > > > > Symbicort). The highest risk-difference estimates

for the

> > > > composite

> > > > > > > > > endpoint were in children aged 4-11 years (14.8 per 1000

> > > > > > subjects) among

> > > > > > > > > age groups and in blacks (8.1 per 1000 subjects)

among race

> > > > > > subgroups.

> > > > > > > > >

> > > > > > > > > Comment: Overall, Advair is clearly the most popular of

> > the four

> > > > > > drugs,

> > > > > > > > > with annual worldwide sales of US$5.7 billion

(compared with

> > > > > > US$209-$538

> > > > > > > > > million for the other 3 drugs). In children and

adolescents,

> > > > use of

> > > > > > > > > Advair is common, and use of the other three drugs is

> > > > limited. For

> > > > > > > > > children whose asthma symptoms are not controlled with

> > > > low-dose ICS,

> > > > > > > > > questions remain about whether increasing the ICS dose

> > is better

> > > > > > than

> > > > > > > > > adding other drugs. Current National Heart, Lung and

Blood

> > > > Institute

> > > > > > > > > stepwise recommendations for management of asthma

> > > > > > > > >

> > > > > >

> > <http://imageb.epocrates.com/mailbot/links?EdID=39985581 & LinkID=35731>

> > > > > > > > > are as follows:

> > > > > > > > >

> > > > > > > > > Children aged <5 years:

> > > > > > > > > -Step 3 care: medium-dose ICS

> > > > > > > > > -Step 4 care: medium-dose ICS plus either LABA or

> > montelukast

> > > > > > > > >

> > > > > > > > > Children aged 5-11 years:

> > > > > > > > > -Step 3 care: either low-dose ICS plus LABA, a

leukotriene

> > > > > > inhibitor, or

> > > > > > > > > theophylline; or medium-dose ICS

> > > > > > > > > -Step 4 care: medium-dose ICS plus LABA

> > > > > > > > >

> > > > > > > > > - Bauchner, MD

> > > > > > > > >

> > > > > >

> > <http://imageb.epocrates.com/mailbot/links?EdID=39985581 & LinkID=35733>

> > > > > > > > >

> > > > > > > > > Published in Journal Watch Pediatrics and Adolescent

> > Medicine

> > > > > > December

> > > > > > > > > 24, 2008

> > > > > > > > >

> > > > > > > >

> > > > > > >

> > > > > >

> > > > >

> > > >

> > >

> >

>

February 25, 2009

I used to have pretty severe bleeding issues. My gyno did a D & C, which

didn't help. He recommended I try Mirena, which is an intrauterine

contraceptive, before we went as drastic as a hysterectomy. I've had

Mirena for 2 years and almost never bleed at all. On the rare occasion

that I do, it's just spotting for a day. Some users end up never

having periods at all. Not to mention that it's an extremely reliable

source of birth control, but that wasn't my reason for using it. It

might be worth your checking into it.

> >

> > Subject: Re: Re: prednisone side effects

> > To: asthma

> > Date: Sunday, February 22, 2009, 8:24 PM

> >

> > -- no menstruation and such --

> > Do you have problems with your potassium? I have -- from the Pred and

> > asthma medications. They deplete my potassium. I am always low on

it so I

> > take supplements (doctor-prescribed too because the dose is

outside of the

> > normal non-prescription stuff) and sometimes have to be in the

hospital for

> > IV potassium. I have heart issues and the low potassium messes up

my heart

> > even more so I can't just ignore it.

> > Recent Activity

> >

> > - 8

> > New

Members<http://groups.yahoo..com/group/asthma/members;_ylc=X3oDMTJjbXVtcTVqBF9TA\

zk3MzU5NzE0BGdycElkAzI0NTYEZ3Jwc3BJZAMxNzA1MDYxNjEzBHNlYwN2dGwEc2xrA3ZtYnJzBHN0a\

W1lAzEyMzUzNTk0NTM->

> >

> > Visit Your Group

> >

<http://groups.yahoo.com/group/asthma;_ylc=X3oDMTJiaTVhMTE4BF9TAzk3MzU5NzE0BGdyc\

ElkAzI0NTYEZ3Jwc3BJZAMxNzA1MDYxNjEzBHNlYwN2dGwEc2xrA3ZnaHAEc3RpbWUDMTIzNTM1OTQ1M\

w-->

> > Give Back

> > Yahoo! for

Good<http://us.lrd.yahoo.com/_ylc=X3oDMTJqMDlzaGhuBF9TAzk3MzU5NzE0BF9wAzEEZ3JwSW\

QDMjQ1NgRncnBzcElkAzE3MDUwNjE2MTMEc2VjA25jbW9kBHNsawNicmFuZARzdGltZQMxMjM1MzU5ND\

Uz;_ylg=1/SIG=11314uv3k/**http%3A//brand.yahoo.com/forgood>

> >

> > Get inspired

> >

> > by a good cause.

> > Y! Toolbar

> > Get it

Free!<http://us.lrd.yahoo.com/_ylc=X3oDMTJsbjBuOWpsBF9TAzk3MzU5NzE0BF9wAzIEZ3JwS\

WQDMjQ1NgRncnBzcElkAzE3MDUwNjE2MTMEc2VjA25jbW9kBHNsawN0b29sYmFyBHN0aW1lAzEyMzUzN\

Tk0NTM-;_ylg=1/SIG=11c6dvmk9/**http%3A//toolbar.yahoo.com/%3F.cpdl=ygrps>

> >

> > easy 1-click access

> >

> > to your groups.

> > Yahoo! Groups

> > Start a

group<http://groups.yahoo.com/start;_ylc=X3oDMTJscXUzNjZxBF9TAzk3MzU5NzE0BF9wAzM\

EZ3JwSWQDMjQ1NgRncnBzcElkAzE3MDUwNjE2MTMEc2VjA25jbW9kBHNsawNncm91cHMyBHN0aW1lAzE\

yMzUzNTk0NTM->

> >

> > in 3 easy steps.

> >

> > Connect with others.

> > .

> >

>

Sign In

Re: prednisone side effects

Recommended Posts

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Guest guest

Link to comment

Share on other sites

Join the conversation

Activity